NCT00003512 2018-02-05Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's MacroglobulinemiaBurzynski Research InstitutePhase 2 Withdrawn
NCT00003502 2013-07-10Antineoplaston Therapy in Treating Patients With Mantle Cell LymphomaNational Cancer Institute (NCI)Phase 2 Withdrawn